Skip to main content

Investors

Investors

Home › Home › Press Releases

Press Releases
Press Release RSS Feed (opens in new window)
Press release year list 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
December 21, 2017
Ironwood Pharmaceuticals Initiates Phase II Clinical Trial of sGC Stimulator IW-1701 in Patients with Sickle Cell Disease
Download PDF format download (opens in new window)
December 4, 2017
Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects
Download PDF format download (opens in new window)
November 28, 2017
Ironwood Pharmaceuticals Strengthens Executive Leadership Team
Download PDF format download (opens in new window)
November 2, 2017
Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update
Download PDF format download (opens in new window)
November 1, 2017
Ironwood Pharmaceuticals to Present at Credit Suisse 26th Annual Healthcare Conference
Download PDF format download (opens in new window)
October 30, 2017
Ironwood Highlights Breadth of Gout Research to be Presented at the 2017 ACR/ARHP Annual Meeting
Download PDF format download (opens in new window)
October 19, 2017
Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call
Download PDF format download (opens in new window)
October 16, 2017
Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017
Download PDF format download (opens in new window)
September 6, 2017
Ironwood Pharmaceuticals Announces Leadership Change
Download PDF format download (opens in new window)
August 31, 2017
Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Download PDF format download (opens in new window)
August 21, 2017
Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
Download PDF format download (opens in new window)
August 3, 2017
Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update
Download PDF format download (opens in new window)
July 20, 2017
Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call
Download PDF format download (opens in new window)
July 20, 2017
Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease
Download PDF format download (opens in new window)
June 8, 2017
Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
Download PDF format download (opens in new window)
June 1, 2017
Ironwood Pharmaceuticals to Present at the Jefferies Healthcare Conference
Download PDF format download (opens in new window)
May 10, 2017
Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
Download PDF format download (opens in new window)
May 9, 2017
Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide's Effect on Pain at Digestive Disease Week® 2017
Download PDF format download (opens in new window)
May 8, 2017
Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update
Download PDF format download (opens in new window)
May 1, 2017
Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017
Download PDF format download (opens in new window)
April 24, 2017
Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
Download PDF format download (opens in new window)
April 13, 2017
Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)
Download PDF format download (opens in new window)
April 6, 2017
Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer
Download PDF format download (opens in new window)
March 10, 2017
Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Download PDF format download (opens in new window)
March 9, 2017
Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017
Download PDF format download (opens in new window)
February 28, 2017
Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference
Download PDF format download (opens in new window)
February 23, 2017
Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017
Download PDF format download (opens in new window)
February 21, 2017
Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update
Download PDF format download (opens in new window)
February 7, 2017
Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call
Download PDF format download (opens in new window)
January 29, 2017
Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial for Patients with Chronic Constipation Conducted in Japan
Download PDF format download (opens in new window)
January 26, 2017
U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation
Download PDF format download (opens in new window)
January 8, 2017
Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech
Download PDF format download (opens in new window)
January 4, 2017
Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors
Download PDF format download (opens in new window)
January 4, 2017
Ironwood Announces New Drug Application for DUZALLO™ (Fixed-Dose Combination of Lesinurad and Allopurinol) Has Been Accepted for FDA Review
Download PDF format download (opens in new window)
January 3, 2017
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)